Usage of glaucoma-specific patient-reported outcome measures (PROMs) in the Singapore context: a qualitative scoping exercise

about

Usage of glaucoma-specific patient-reported outcome measures (PROMs) in the Singapore context: a qualitative scoping exercise

Item

http://www.wikidata.org/entity/Q58782414

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Usage of glaucoma-specific pat ...... a qualitative scoping exercise

@en

Usage of glaucoma-specific patient-reported outcome measures

@nl

type

Item

label

Usage of glaucoma-specific pat ...... a qualitative scoping exercise

@en

Usage of glaucoma-specific patient-reported outcome measures

@nl

prefLabel

Usage of glaucoma-specific pat ...... a qualitative scoping exercise

@en

Usage of glaucoma-specific patient-reported outcome measures

@nl

P1476

Usage of glaucoma-specific pat ...... a qualitative scoping exercise

@en

P2093

Ecosse Luc Lamoureux

http://www.w3.org/2001/XMLSchema#string

Hong-Yuan Zhu

http://www.w3.org/2001/XMLSchema#string

Owen Kim Hee

http://www.w3.org/2001/XMLSchema#string

Zheng-Xian Thng

http://www.w3.org/2001/XMLSchema#string

P2860

A new measure of patient satisfaction with ocular hypotensive medications: the Treatment Satisfaction Survey for Intraocular Pressure (TSS-IOP)

The impact of glaucoma on the quality of life of patients in Norway. I. Results from a self-administered questionnaire.

Which quality of life score is best for glaucoma patients and why?

Pre-validation methods for developing a patient reported outcome instrument.

Pragmatic randomised trials using routine electronic health records: putting them to the test.

Outcome Measures in Glaucoma: A Systematic Review of Cochrane Reviews and Protocols.

Patient-reported outcomes (PRO's) in glaucoma: a systematic review

Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001.

Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels.

The development, assessment, and selection of questionnaires.

P2888

s12886-018-0803-5

P304

197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12886-018-0803-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106149705

http://www.w3.org/2001/XMLSchema#string

P698

30107834

http://www.w3.org/2001/XMLSchema#string

P932

6092864

http://www.w3.org/2001/XMLSchema#string